Document is current
Any future updates will be listed below
-
Authors
Tarney, Christopher M.
Mhawech-Fauceglia, Paulette
Ogata, Jonathan D.
Oliver, Julie
Abulez, Tamara
Branton, Philip A.
Movahedi-Lankarani, Saeid
Hood, Brian L.
Conrads, Kelly A.
Rosalik, Kendal
Wong, Kwong-Kwok
Gershenson, David M.
Lee, Sanghoon
Sood, Anil K.
Bast, Robert C. Jr.
Darcy, Kathleen M.
Phippen, Neil T.
Maxwell, G. Larry
Conrads, Thomas P.
Bateman, Nicholas W.
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 28 August 2025
First Online: 6 October 2025
Declarations
:
: Formalin-fixed, paraffin-embedded (FFPE) LGSOC and HGSOC tumor and normal fallopian tube tissues were obtained from Inova Fairfax Hospital (Falls Church, VA) under a less than minimal-risk WCG IRB-approved protocol #20122048 with waivers for consent and HIPAA authorization and evaluated under protocol #14-1679 with an exempt determination by the WCG IRB in accordance with the use of de-identified data under US Federal regulation 45 CFR 46.102(f).
: Not applicable.
: The authors declare no competing interests.
: The views expressed herein are those of the authors and do not reflect the official policy of the Uniformed Services University of the Health Sciences, the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Inova Health System, the Department of Army/Navy/Air Force, Department of Defense, or U.S. Government. Mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government.
